Special Offer: Purchase TWO and get ONE free.**
Philadelphia, PA / ACCESSWIRE / Olfactory Biosciences Corp.’s (OLFC) Chief Scientist Dr. V. Ruth Pinney and developer of NOXO’s eleven natural Wellness products, announced the two top products based on sales and effectiveness for 2013.
In first place, NOXO Autism Aid Balm(TM) was noted by Dr. Pinney that what makes it unique is that it, "Is a simple, but powerful way to ‘tone down’ sensory overwhelming perceptions. (http://www.noxoinfo.com/autism)
The Autism Balm works well with most children that have Autism Spectrum Disorders (ASD). It is successful because it targets sensitivities naturally, changing the child's perception to sensory inputs in a direct, safe way!
Jacqueline de Vries, Director, Crossroads Center of NJ, reported that a high functioning ASD, 11-year old girl client has been using NOXO Autism Balm™ for a month. She applies the balm each day before she goes to school. She applies a second application when she arrives home. Prior to NOXO, she was experiencing severe meltdowns several times per week, upon returning home. Now, at most she has had one or two mild issues per week. Mom says Thank You! My assessment is that it is easing her anxiety during her academic school day, so she is not so tense and explosive when she gets home. An easier time for all involved.
Over 90% of those using NOXO and responding to a survey indicate that NOXO Autism Balm(TM) is as effective as are the claims.
Dr. Pinney’s second place NOXO Anxiety Relief Pro(TM) is the resulting combination of NOBEL Prize Winning in Medicine, in 2004, (Richard Axel and Linda Buck), and NOXO’s advanced olfactory receptor administration delivery system. Unlike popular and addictive "Benzo" drugs which are commonly prescribed and taken internally, and include Xanax(R), Ativan(R), Klonopin(R) and more, NOXO Anxiety Relief Pro(TM) is a topical alternative medicine and is applied under the nose where the olfactory receptors of the brain pick up the scents and stimulate the release of powerful neurotransmitters.
NOXO Anxiety Relief Pro(TM) has 16 proven effective natural phytochemicals and can replace the "Benzo"s, which are selective serotonin reuptake inhibitors (SSRIs), and are ingested and have complicated side effects and withdrawal difficulties.
New NOXO Anxiety Relief Pro(TM) reduces anxiety associated with panic attacks, shortness of breath, dizziness, hot flashes and/or chills and reduces the startle reaction; also called the startle response, startle reflex or alarm reaction. All this and no side effects, nothing to take into your body and no untoward reactions with other medications.
Generally regarded as safe ( GRAS ) NOXO Anxiety Relief Pro(TM) is not habit forming.
Anxiety is a common complaint and may range from every day stress to clinically relevant symptoms requiring medical intervention. Patients with generalized anxiety disorder (GAD) can experience excessive anxiety and worry associated with the stresses of everyday life. And now, those with GAD can find relief with NOXO Anxiety Relief Pro(TM)
Thirty Day Special Offer: Buy two balms and receive a coupon to get a third one free. Instructions included in package.
More about NOXO Anxiety Defense Pro(TM) at www.noxoinfo.com/anxiety
About Olfactory Biosciences Corp
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples.
This company has taken NOBEL Prize Winning in Medicine, in 2004, (Richard Axel and Linda Buck) related to discoveries of olfactory receptors in the nose and has developed unique wellness products with an advanced delivery system, that are affordable and made from natural ingredients.
Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today.
Olfactory Biosciences Corp’s unique advantages will make NOXO products the most sought-after wellness products in the alternative medicine market with the company anticipating rapid growth. www.noxoinfo.com/investor
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding sales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risk and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere.
The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp., Inc.
333 E. Lancaster Ave.
Wynnewood, PA 19096 USA